CELL & GENE: THE PODCAST

24:24 23_12_CGPodcast_1280x720_Ep94
The Future of NK Cell Therapy for Autoimmune Disease with Artiva Biotherapeutics' Christopher Horan

Christopher Horan, Chief Technical Operations Officer, Artiva Biotherapeutics joins Cell & Gene: The Podcast Host, Erin Harris, to discuss the advantages natural killer (NK) cells have offer over T cells in terms of safety and efficacy for autoimmune disease. They tak...

THE VOICES OF A BURGEONING MARKET

Cell & Gene, the most valuable resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, brings you Cell & Gene: The Podcast. Each episode explores approved and pipeline therapies, new trends in manufacturing, the long, regulated road to commercialization, and everything in between.

FEATURED GUESTS

Christopher Horan
Artiva Biotherapeutics
PLAY
Christopher Choi
Roswell Park Comprehensive Cancer Center
PLAY
Lothar Roessig
Asklepios BioPharmaceutical
PLAY
Amit Rahkit
BlueRock Therapeutics
PLAY
Rita Johnson-Greene
Alliance for Regenerative Medicine
PLAY
Dennis Williams
Adaptimmune
PLAY
Miguel Forte
Kiji Therapeutics
PLAY
Carsten Linnemann
Neogene Therapeutics
PLAY
Paul Bresge
Ray Therapeutics
PLAY
Michael Severino
Tessera Therapeutics
PLAY
Zachary Roberts
Allogene Therapeutics
PLAY
Debra Miller
CureDuchenne
PLAY
Michael Kelly
CureDuchenne
PLAY
Lucas Harrington
Mammoth Biosciences
PLAY
Micah Benson
KSQ Therapeutics
PLAY
Aki Ko
Elixirgen Therapeutics
PLAY
Bambi Grilley
ISCT
PLAY
Bruce Levine
University of Pennsylvania
PLAY
Ahmed Enayetallah
Dompé
PLAY
Robert Ang
Vor Bio
PLAY
Scott McClellan
Orca Bio
PLAY
Sharon Rosenzweig-Lipson
Life Biosciences
PLAY
Cat Lutz
The Jackson Laboratory
PLAY
Peter Marks
FDA
PLAY
Karen Kozarsky
SwanBio Therapeutics
PLAY
Rachelle Jacques
Akari Therapeutics
PLAY
Apple Spotify   YouTube

MEET THE HOST

Matty PHosted by Cell & Gene Chief Editor Erin Harris, Cell & Gene: The Podcast interviews industry and academic leaders on what they’re working on and how it's moving the sector forward.

LINKEDIN

Interested in joining us on air? Contact us

RECENT EPISODES

24:24 23_12_CGPodcast_1280x720_Ep94

The Future of NK Cell Therapy for Autoimmune Disease with Artiva Biotherapeutics' Christopher Horan

14:49 23_12_CGPodcast_1280x720_Ep93

Lessons in Automation with Roswell Park Comprehensive Cancer Center's Christopher Choi, Ph.D.

21:08 23_12_CGPodcast_1280x720_Ep92

Can Gene Therapy Be The Solution For CHF With AskBio's Dr. Lothar Roessig

31:14 23_12_CGPodcast_1280x720_Ep91

Inside A Dopamine-Restoring Cell Therapy For PD With BlueRock Therapeutics' Dr. Amit Rakhit

21:39 23_12_CGPodcast_1280x720_Ep90

Globalization's Impact on Patient Access with ARM's COO, Rita Johnson-Greene

20:52 23_12_CGPodcast_1280x720_Ep89

Improving TCR T-Cell Persistence and Efficacy with Adaptimmune's Dennis Williams

25:26 23_12_CGPodcast_1280x720_Ep88

Live from ARM's Meeting on the Mesa with Kiji Therapeutics' Dr. Miguel Forte

14:18 23_12_CGPodcast_1280x720_Ep87

Pioneering Next-Gen TCR Therapies In Solid Tumors With Neogene Therapeutics' Carsten Linnemann, Ph.D.

22:00 23_12_CGPodcast_1280x720_Ep86

Optogenetics for Vision Restoration with Ray Therapeutics' Paul Bresge

28:06 23_12_CGPodcast_1280x720_Ep85

A New Approach to Genome Engineering with Tessera Therapeutics' Dr. Michael Severino

25:13 23_12_CGPodcast_1280x720_Ep84

Scaling Allo with Allogene Therapeutics' Dr. Zachary Roberts

27:58 23_12_CGPodcast_1280x720_Ep83

CGT Regulatory Update and Outlook with Dark Horse Consulting's Kimberly Benton, Ph.D.

29:55 23_12_CGPodcast_1280x720_Ep82

Identifying Drug Development Opportunities For DMD With CureDuchenne

21:01 23_12_CGPodcast_1280x720_Ep81

Tackling 'The Delivery Problem' Of Gene Editing-Based Medicines

35:29 23_12_CGPodcast_1280x720_Ep80

TILs for the Treatment of Solid Tumors with KSQ Therapeutics' Micah Benson, Ph.D.

14:52 23_12_CGPodcast_1280x720_Ep78

Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko

25:21 23_12_CGPodcast_1280x720_Ep77

The Current State of the Global Regulatory Landscape with ISCT's Dr. Bambi Grilley

31:48 23_12_CGPodcast_1280x720_Ep76

Dr. Bruce Levine on ISCT and the Future of CAR-T

18:50 23_12_CGPodcast_1280x720_Ep75

CGTs for HIV Suppression with Addimmune's Dr. Marcus Conant

29:39 23_12_CGPodcast_1280x720_Ep74

Inside BlueRock Therapeutics' Parkinson's Disease Trial with Dr. Ahmed Enayetallah

23:08 23_12_CGPodcast_1280x720_Ep73

Reducing the Disease Burden of AML with Vor Bio's Dr. Robert Ang

19:37 23_12_CGPodcast_1280x720_Ep72

Reducing Toxicities in Allogeneic Cell Therapies with Orca Bio's Dr. Scott McClellan

17:17 23_12_CGPodcast_1280x720_Ep71

Inside Cellular Rejuvenation Therapies for Age-Related Diseases with Life Biosciences' Sharon Rosenzweig-Lipson, Ph.D.

27:31 23_12_CGPodcast_1280x720_Ep70

The Future of Rare Diseases with The Jackson Laboratory's Rare Disease Translational Center's Cat Lutz

20:48 23_12_CGPodcast_1280x720_Ep69

Inside Yescarta's Reduced Median Turnaround Time with Kite, a Gilead Company's Christopher McDonald

37:17 23_12_CGPodcast_1280x720_Ep68

Pricing, Value, And Access of CGTs With The Dedham Group's Jennifer Klarer, M.Sc.Eng.

21:33 23_12_CGPodcast_1280x720_Ep67

Breaking Down Solid Tumors With Triumvira Immunologics' Dr. Paul Lammers

31:59 23_12_CGPodcast_1280x720_Ep66

4 Keys To Allo In 2024 With Poseida Therapeutics' Kristin Yarema, Ph.D.

17:23 21_06_Cell&GeneThePodcast_Video_Ep64

Overcoming The Limitations Of CAR T-Cell Therapy With Vittoria Bio's Nick Siciliano, Ph.D.

28:34 21_06_Cell&GeneThePodcast_Video_Ep62

The Promise Of AAV Gene Therapy With REGENXBIO's Ken Mills

18:15 21_06_Cell&GeneThePodcast_Video_Ep60

The Future Of Cell And Organ Transplantation In Treating T1D With Dr. Camillo Ricordi

30:37 21_06_Cell&GeneThePodcast_Video_Ep59

In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg

25:17 21_06_Cell&GeneThePodcast_Video_Ep58

Inside Genome Editing With CBER's Dr. Peter Marks

25:53 21_06_Cell&GeneThePodcast_Video_Ep57

The Future Of CAR-T With Bristol Myers Squibb's Lynelle Hoch

23:21 21_06_Cell&GeneThePodcast_Video_Ep56

The Promise Of Genome Editing With Caribou Biosciences' Rachel Haurwitz, Ph.D.

29:16 21_06_Cell&GeneThePodcast_Video_Ep54

The Intersection Of RNA, AI, And Synthetic Biology With Shape Therapeutics' Dr. Francois Vigneault

24:34 21_06_Cell&GeneThePodcast_Video_Ep53

Inside Prime Editing With Prime Medicine's Dr. Andrew Anzalone

27:37 21_06_Cell&GeneThePodcast_Video_Ep51

Dr. Usman "Oz" Azam Discusses The State Cell And Gene Therapy Space

23:45 21_06_Cell&GeneThePodcast_Video_Ep50

Targeting Oncogenic Drivers for Solid Tumor Cancers with Affini-T Therapeutics' Dr. Jak Knowles

42:20 21_06_Cell&GeneThePodcast_Video_Ep49

TJU's Jefferson Institute for Bioprocessing's Impact on CGT with Parviz Shamlou

31:57 21_06_Cell&GeneThePodcast_Video_Ep48

Computational Biology's Role In Gene Therapy With Kriya Therapeutics' Dr. Shankar Ramaswamy

28:17 21_06_Cell&GeneThePodcast_Video_Ep47

The Near-Term Future Of Exosome Science With Capricor Therapeutics' Dr. Linda Marbán

40:51 21_06_Cell&GeneThePodcast_Video_Ep46

Inside The World's First-Ever Allogeneic Approval With Atara Biotherapeutics' Pascal Touchon

20:40 21_06_Cell&GeneThePodcast_Video_Ep45

The Potential Of RNA Exon Editing With Ascidian Therapeutics' Romesh Subramanian, Ph.D.

31:52 21_06_Cell&GeneThePodcast_Video_Ep44

Automating Processes To Scale CGT Manufacturing With PA Consulting's Paolo Siciliano

21:42 21_06_Cell&GeneThePodcast_Video_Ep43

The Why Behind In-House Manufacturing With Sangamo's Andy Ramelmeier

26:34 21_06_Cell&GeneThePodcast_Video_Ep42

2023 Market Outlook with AdBio and ISCT's Miguel Forte

36:05 21_06_Cell&GeneThePodcast_Video_Ep41

CMC And Scale Up With Mustang Bio's Robert Sexton

28:34 22_01_C&GPodcast_1280x720_ep40

An Interview with Dr. Peter Marks

26:57 22_01_C&GPodcast_1280x720_Ep39

Inside NK and Macrophage Cellular Immunotherapies

28:35 21_06_Cell&GeneThePodcast_Video_Ep38

The Future Of iPSCs With BlueRock Therapeutics' CEO Seth Ettenberg

36:45 21_06_Cell&GeneThePodcast_Video_Ep37

Manufacturing at the Point of Care with Orgenesis' CEO Vered Caplan

40:25 21_06_Cell&GeneThePodcast_Video_Ep36

Capstan Therapeutics' CEO Laura Shawver On In Vivo Cell Engineering

32:43 21_06_Cell&GeneThePodcast_Video_Ep33

Inside RNAi With Arrowhead Pharmaceuticals' Javier San Martin

22:48 21_06_cell_genethepodcast_video_ep32

Planning For Manufacturing Capacity With Kite Pharma's Will Junker

19:55 22_01_cgpodcast_1200x628_ep31

Commercialization Learnings With Novartis Gene Therapies' President Chris Fox

27:40 22_01_cgpodcast_1200x628_ep30

A Stem Cell-Derived Treatment For T1D

27:42 22_07_CellGeneThePodcast_YouTubeThumbnail_ep28

An Interview With Dr. Carl June

28:24 21_06_CellGeneThePodcast_Video_Ep29

Best Practices For Partnering With A CDMO

18:50 22_01_CGPodcast_1200x628_Ep18

Restoration of Immune Balance with Anish Suri, Ph.D., President and CSO at Cue Biopharma

20:15 21_06_CGPodcast_1200x628_Ep6.2

Gene Therapies For Spinal Cord-Related Disorders With SwanBio's CSO

30:23 21_06_CGPodcast_1200x628_Ep2

Hospital Systems & Complex Therapies With University Of Pennsylvania Health System's Kevin Mahoney

25:55 21_06_CGPodcast_1200x628_Ep4

State-of-the-Art GMP Manufacturing RNA Cell Therapies With Cartesian's CEO

24:15 The Future of Tissue-Based Therapies

The Future of Tissue-Based Therapies

More Recent Episodes

CLINICAL TRIALS

29:16 21_06_Cell&GeneThePodcast_Video_Ep54

The Intersection Of RNA, AI, And Synthetic Biology With Shape Therapeutics' Dr. Francois Vigneault

18:50 23_12_CGPodcast_1280x720_Ep75

CGTs for HIV Suppression with Addimmune's Dr. Marcus Conant

40:25 21_06_Cell&GeneThePodcast_Video_Ep36

Capstan Therapeutics' CEO Laura Shawver On In Vivo Cell Engineering

22:00 23_12_CGPodcast_1280x720_Ep86

Optogenetics for Vision Restoration with Ray Therapeutics' Paul Bresge

28:06 23_12_CGPodcast_1280x720_Ep85

A New Approach to Genome Engineering with Tessera Therapeutics' Dr. Michael Severino

25:13 23_12_CGPodcast_1280x720_Ep84

Scaling Allo with Allogene Therapeutics' Dr. Zachary Roberts

23:45 21_06_Cell&GeneThePodcast_Video_Ep50

Targeting Oncogenic Drivers for Solid Tumor Cancers with Affini-T Therapeutics' Dr. Jak Knowles

20:52 23_12_CGPodcast_1280x720_Ep89

Improving TCR T-Cell Persistence and Efficacy with Adaptimmune's Dennis Williams

14:18 23_12_CGPodcast_1280x720_Ep87

Pioneering Next-Gen TCR Therapies In Solid Tumors With Neogene Therapeutics' Carsten Linnemann, Ph.D.

23:08 23_12_CGPodcast_1280x720_Ep73

Reducing the Disease Burden of AML with Vor Bio's Dr. Robert Ang

19:37 23_12_CGPodcast_1280x720_Ep72

Reducing Toxicities in Allogeneic Cell Therapies with Orca Bio's Dr. Scott McClellan

25:26 23_12_CGPodcast_1280x720_Ep88

Live from ARM's Meeting on the Mesa with Kiji Therapeutics' Dr. Miguel Forte

29:39 23_12_CGPodcast_1280x720_Ep74

Inside BlueRock Therapeutics' Parkinson's Disease Trial with Dr. Ahmed Enayetallah

21:08 23_12_CGPodcast_1280x720_Ep92

Can Gene Therapy Be The Solution For CHF With AskBio's Dr. Lothar Roessig

More on Clinical Trials

DISCOVERY

29:16 21_06_Cell&GeneThePodcast_Video_Ep54

The Intersection Of RNA, AI, And Synthetic Biology With Shape Therapeutics' Dr. Francois Vigneault

40:25 21_06_Cell&GeneThePodcast_Video_Ep36

Capstan Therapeutics' CEO Laura Shawver On In Vivo Cell Engineering

25:17 21_06_Cell&GeneThePodcast_Video_Ep58

Inside Genome Editing With CBER's Dr. Peter Marks

14:52 23_12_CGPodcast_1280x720_Ep78

Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko

31:14 23_12_CGPodcast_1280x720_Ep91

Inside A Dopamine-Restoring Cell Therapy For PD With BlueRock Therapeutics' Dr. Amit Rakhit

21:01 23_12_CGPodcast_1280x720_Ep81

Tackling 'The Delivery Problem' Of Gene Editing-Based Medicines

21:39 23_12_CGPodcast_1280x720_Ep90

Globalization's Impact on Patient Access with ARM's COO, Rita Johnson-Greene

17:17 23_12_CGPodcast_1280x720_Ep71

Inside Cellular Rejuvenation Therapies for Age-Related Diseases with Life Biosciences' Sharon Rosenzweig-Lipson, Ph.D.

27:31 23_12_CGPodcast_1280x720_Ep70

The Future of Rare Diseases with The Jackson Laboratory's Rare Disease Translational Center's Cat Lutz

20:52 23_12_CGPodcast_1280x720_Ep89

Improving TCR T-Cell Persistence and Efficacy with Adaptimmune's Dennis Williams

14:18 23_12_CGPodcast_1280x720_Ep87

Pioneering Next-Gen TCR Therapies In Solid Tumors With Neogene Therapeutics' Carsten Linnemann, Ph.D.

25:26 23_12_CGPodcast_1280x720_Ep88

Live from ARM's Meeting on the Mesa with Kiji Therapeutics' Dr. Miguel Forte

35:29 23_12_CGPodcast_1280x720_Ep80

TILs for the Treatment of Solid Tumors with KSQ Therapeutics' Micah Benson, Ph.D.

24:24 23_12_CGPodcast_1280x720_Ep94

The Future of NK Cell Therapy for Autoimmune Disease with Artiva Biotherapeutics' Christopher Horan

21:08 23_12_CGPodcast_1280x720_Ep92

Can Gene Therapy Be The Solution For CHF With AskBio's Dr. Lothar Roessig

24:34 21_06_Cell&GeneThePodcast_Video_Ep53

Inside Prime Editing With Prime Medicine's Dr. Andrew Anzalone

20:15 21_06_CGPodcast_1200x628_Ep6.2

Gene Therapies For Spinal Cord-Related Disorders With SwanBio's CSO

29:55 23_12_CGPodcast_1280x720_Ep82

Identifying Drug Development Opportunities For DMD With CureDuchenne

More on Discovery

MANUFACTURING

32:43 21_06_Cell&GeneThePodcast_Video_Ep33

Inside RNAi With Arrowhead Pharmaceuticals' Javier San Martin

28:17 21_06_Cell&GeneThePodcast_Video_Ep47

The Near-Term Future Of Exosome Science With Capricor Therapeutics' Dr. Linda Marbán

37:17 23_12_CGPodcast_1280x720_Ep68

Pricing, Value, And Access of CGTs With The Dedham Group's Jennifer Klarer, M.Sc.Eng.

28:34 22_01_C&GPodcast_1280x720_ep40

An Interview with Dr. Peter Marks

36:45 21_06_Cell&GeneThePodcast_Video_Ep37

Manufacturing at the Point of Care with Orgenesis' CEO Vered Caplan

21:42 21_06_Cell&GeneThePodcast_Video_Ep43

The Why Behind In-House Manufacturing With Sangamo's Andy Ramelmeier

23:21 21_06_Cell&GeneThePodcast_Video_Ep56

The Promise Of Genome Editing With Caribou Biosciences' Rachel Haurwitz, Ph.D.

24:15 The Future of Tissue-Based Therapies

The Future of Tissue-Based Therapies

18:50 22_01_CGPodcast_1200x628_Ep18

Restoration of Immune Balance with Anish Suri, Ph.D., President and CSO at Cue Biopharma

27:40 22_01_cgpodcast_1200x628_ep30

A Stem Cell-Derived Treatment For T1D

30:37 21_06_Cell&GeneThePodcast_Video_Ep59

In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg

21:33 23_12_CGPodcast_1280x720_Ep67

Breaking Down Solid Tumors With Triumvira Immunologics' Dr. Paul Lammers

17:23 21_06_Cell&GeneThePodcast_Video_Ep64

Overcoming The Limitations Of CAR T-Cell Therapy With Vittoria Bio's Nick Siciliano, Ph.D.

26:34 21_06_Cell&GeneThePodcast_Video_Ep42

2023 Market Outlook with AdBio and ISCT's Miguel Forte

20:40 21_06_Cell&GeneThePodcast_Video_Ep45

The Potential Of RNA Exon Editing With Ascidian Therapeutics' Romesh Subramanian, Ph.D.

20:48 23_12_CGPodcast_1280x720_Ep69

Inside Yescarta's Reduced Median Turnaround Time with Kite, a Gilead Company's Christopher McDonald

27:42 22_07_CellGeneThePodcast_YouTubeThumbnail_ep28

An Interview With Dr. Carl June

28:35 21_06_Cell&GeneThePodcast_Video_Ep38

The Future Of iPSCs With BlueRock Therapeutics' CEO Seth Ettenberg

25:53 21_06_Cell&GeneThePodcast_Video_Ep57

The Future Of CAR-T With Bristol Myers Squibb's Lynelle Hoch

18:15 21_06_Cell&GeneThePodcast_Video_Ep60

The Future Of Cell And Organ Transplantation In Treating T1D With Dr. Camillo Ricordi

31:59 23_12_CGPodcast_1280x720_Ep66

4 Keys To Allo In 2024 With Poseida Therapeutics' Kristin Yarema, Ph.D.

31:52 21_06_Cell&GeneThePodcast_Video_Ep44

Automating Processes To Scale CGT Manufacturing With PA Consulting's Paolo Siciliano

40:51 21_06_Cell&GeneThePodcast_Video_Ep46

Inside The World's First-Ever Allogeneic Approval With Atara Biotherapeutics' Pascal Touchon

25:55 21_06_CGPodcast_1200x628_Ep4

State-of-the-Art GMP Manufacturing RNA Cell Therapies With Cartesian's CEO

19:55 22_01_cgpodcast_1200x628_ep31

Commercialization Learnings With Novartis Gene Therapies' President Chris Fox

36:05 21_06_Cell&GeneThePodcast_Video_Ep41

CMC And Scale Up With Mustang Bio's Robert Sexton

28:34 21_06_Cell&GeneThePodcast_Video_Ep62

The Promise Of AAV Gene Therapy With REGENXBIO's Ken Mills

31:57 21_06_Cell&GeneThePodcast_Video_Ep48

Computational Biology's Role In Gene Therapy With Kriya Therapeutics' Dr. Shankar Ramaswamy

14:49 23_12_CGPodcast_1280x720_Ep93

Lessons in Automation with Roswell Park Comprehensive Cancer Center's Christopher Choi, Ph.D.

26:57 22_01_C&GPodcast_1280x720_Ep39

Inside NK and Macrophage Cellular Immunotherapies

30:23 21_06_CGPodcast_1200x628_Ep2

Hospital Systems & Complex Therapies With University Of Pennsylvania Health System's Kevin Mahoney

22:48 21_06_cell_genethepodcast_video_ep32

Planning For Manufacturing Capacity With Kite Pharma's Will Junker

28:24 21_06_CellGeneThePodcast_Video_Ep29

Best Practices For Partnering With A CDMO

31:48 23_12_CGPodcast_1280x720_Ep76

Dr. Bruce Levine on ISCT and the Future of CAR-T

42:20 21_06_Cell&GeneThePodcast_Video_Ep49

TJU's Jefferson Institute for Bioprocessing's Impact on CGT with Parviz Shamlou

More on Manufacturing

REGULATORY

27:58 23_12_CGPodcast_1280x720_Ep83

CGT Regulatory Update and Outlook with Dark Horse Consulting's Kimberly Benton, Ph.D.

25:17 21_06_Cell&GeneThePodcast_Video_Ep58

Inside Genome Editing With CBER's Dr. Peter Marks

25:21 23_12_CGPodcast_1280x720_Ep77

The Current State of the Global Regulatory Landscape with ISCT's Dr. Bambi Grilley

21:39 23_12_CGPodcast_1280x720_Ep90

Globalization's Impact on Patient Access with ARM's COO, Rita Johnson-Greene

27:37 21_06_Cell&GeneThePodcast_Video_Ep51

Dr. Usman "Oz" Azam Discusses The State Cell And Gene Therapy Space

More on Regulatory